Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Adicet Bio Provides Corporate Update and Highlights Expected 2025 Milestones
-
Pat Hafner Promoted to Executive Vice President, President of Outback Steakhouse
-
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
-
Maravai LifeSciences Announces Preliminary Unaudited 2024 Revenue
-
XPO Schedules Fourth Quarter 2024 Earnings Conference Call for Thursday, February 6, 2025
-
Phillips Edison & Company Inc. Invites You to Join Its Fourth Quarter and Full Year 2024 Earnings Conference Call
-
Phillips Edison & Company Inc. Invites You to Join Its Fourth Quarter and Full Year 2024 Earnings Conference Call
-
Saratoga Investment Corp. Announces Fiscal Third Quarter 2025 Financial Results
-
Great Lakes Announces Election of New Director
-
PennantPark Investment Corporation Schedules Earnings Release of First Fiscal Quarter 2025 Results
-
Dyne Therapeutics to Host Investor Conference Call and Webcast to Review New Clinical Data from the ACHIEVE Trial Friday, January 10 at 8:00 a.m. ET
-
Penguin Solutions Reports Q1 Fiscal 2025 Financial Results
-
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates
-
The United States Minority Chamber of Commerce announces a Golden Opportunity for foreign investors
-
Dentalcorp to Participate at Upcoming Investor Conferences
-
Meta to Announce Fourth Quarter and Full Year 2024 Results
-
Dominion Energy Schedules Fourth-Quarter 2024 Earnings Call
-
Gen to Announce Fiscal 2025 Third Quarter Results on January 30, 2025
-
Varex to Participate in CJS Securities 25th Annual New Ideas for the New Year Virtual Conference
-
AppLovin to Announce Fourth Quarter and Full Year 2024 Results
-
New Book ‘Disability Crossroads’ Offers Blueprint for Transforming Disability Services
-
PennantPark Floating Rate Capital Ltd. Schedules Earnings Release of First Fiscal Quarter 2025 Results
-
Siyata Mobile Seizing Strategic Market Opportunities
-
Contineum Therapeutics Completes Enrollment in Phase 2 PIPE-307 VISTA Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)
-
Liberty Media Names Derek Chang as President & Chief Executive Officer
-
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Curbline Properties Fourth Quarter 2024 Investment Update
-
Ameresco Announces Successful Divestiture of Applied Energy Group (AEG) Business, Reinforcing Focus and Reinvesting in Core Businesses
-
Compass to Present at the 27th Annual Needham Growth Conference
-
Duff & Phelps Utility and Infrastructure Fund Inc. Discloses Sources of Distribution – Section 19(a) Notice
-
Everest Group Announces Leadership Transition
-
The ONE Group Hospitality, Inc. to Participate at the 27th Annual ICR Conference
-
Visa to Announce Fiscal First Quarter 2025 Financial Results on January 30, 2025
-
Rocky Brands, Inc. to Present at the 2025 ICR Conference
-
Skechers to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 6th
-
Udemy to Present at Needham’s 27th Annual Growth Conference
-
Root, Inc. to Participate in the 27th Annual ICR Conference
-
Nasdaq Reports December 2024 Volumes and 4Q24 Statistics
-
Solid Biosciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
The Honest Company Announces CFO Retirement and Transition Plan in 2025
-
Terns Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
-
Vigil Neuroscience Highlights 2024 Corporate Achievements and Upcoming 2025 Milestones
-
Definitive Healthcare to Present at the 27th Annual Needham Growth Conference
-
Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
CarGurus to Present at 27th Annual Needham Growth Conference
-
Zymeworks Outlines Strategic Priorities and Outlook for 2025 and 2026
-
Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Ethan Allen Announces Earnings Release Date for its Fiscal 2025 Second Quarter Results
-
DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study
-
Franklin Covey Reports First Quarter Fiscal 2025 Financial Results
